Table of Contents page: Clinical Genitourinary Cancer

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Select all

Download started.
Ok

Please select at least one article in order to proceed.

$Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study$

Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study

Mamta Parikh,
Chong-Xian Pan,
Laurel A. Beckett,
...
Daniel A. Robles,
Pawandeep K. Aujla,
Primo N. Lara Jr.

Published online: July 12, 2018

p421-428.e1

Evaluation of Response to Enzalutamide Consecutively After Abiraterone Acetate/Prednisone Failure in Patients With Metastatic Castration-resistant Prostate Cancer

Hamid Emamekhoo,
Pedro C. Barata,
Natasha C. Edwin,
Kaitlin M. Woo,
Petros Grivas,
Jorge A. Garcia

Published online: August 16, 2018

p429-436

Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma

Michael E. Hurwitz,
Paul Markowski,
Xiaopan Yao,
...
William Kevin Kelly,
Daniel Peter Petrylak,
Janice M. Mehnert

Published online: July 27, 2018

p437-444.e6

Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer

Mihai Dorin Vartolomei,
Matteo Ferro,
Francesco Cantiello,
...
Ottavio de Cobelli,
Vincenzo Mirone,
Shahrokh F. Shariat

Published online: July 05, 2018

p445-452

Laparoscopic Partial Nephrectomy After Selective Embolization and Robot-Assisted Partial Nephrectomy: A Comparison of Short-Term Oncological and Functional Outcomes

Maxime Benoit,
Antoine Bouvier,
Paul Panayotopoulos,
...
Abdel Rahmène Azzouzi,
Philippe Sebe,
Pierre Bigot

Published online: July 12, 2018

p453-457

Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer

Hayley S. McKenzie,
Graham Mead,
Robert Huddart,
...
Nadia Cross,
Megan Bowers,
Matthew J. Wheater

Published online: July 16, 2018

p458-465.e2

Impact of Prior Local Treatment on the Outcomes of Metastatic Hormone-Sensitive Prostate Cancer: Secondary Analysis of a Randomized Controlled Trial

Omar Abdel-Rahman,
Winson Y. Cheung

Published online: July 20, 2018

p466-472

Phase 2 Study of Cyclophosphamide, Etoposide, and Estramustine in Patients With Castration-Resistant Prostate Cancer

Damian A. Laber,
Min-Bin Chen,
Michael Jaglal,
Ankita Patel,
Nathan Visweshwar

Published online: June 27, 2018

p473-481

Clinical Commentary

De Novo, Progressed, and Neglected Metastatic Castration-Sensitive Prostate Cancer: Is One Therapy Fit for All?

Roberto Iacovelli,
Chiara Ciccarese,
Claudia Mosillo,
Giampaolo Tortora

Published online: July 20, 2018

p482-484

Renal Cell Carcinoma Pseudoprogression with Clinical Deterioration: To Hospice and Back

Roy Elias,
Payal Kapur,
Ivan Pedrosa,
James Brugarolas

Published online: July 20, 2018

p485-488

Editorial Board

Published in issue: December 2018

A7-A12

December 2018

Original Studies

Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study

Evaluation of Response to Enzalutamide Consecutively After Abiraterone Acetate/Prednisone Failure in Patients With Metastatic Castration-resistant Prostate Cancer

Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma

Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer

Laparoscopic Partial Nephrectomy After Selective Embolization and Robot-Assisted Partial Nephrectomy: A Comparison of Short-Term Oncological and Functional Outcomes

Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer

Impact of Prior Local Treatment on the Outcomes of Metastatic Hormone-Sensitive Prostate Cancer: Secondary Analysis of a Randomized Controlled Trial

Phase 2 Study of Cyclophosphamide, Etoposide, and Estramustine in Patients With Castration-Resistant Prostate Cancer

Clinical Commentary

De Novo, Progressed, and Neglected Metastatic Castration-Sensitive Prostate Cancer: Is One Therapy Fit for All?

Case Report

Renal Cell Carcinoma Pseudoprogression with Clinical Deterioration: To Hospice and Back

Available Exclusively Online at www.clinical-genitourinary-cancer.com

Spontaneous Regression of a Low-Grade Renal Cell Carcinoma With Oncocytic Features After Renal Mass Biopsy

Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review

Epithelioid Angiosarcoma of the Bladder: A Case Report and Review of the Literature

Sanctuary Testicular Bladder Cancer Metastasis 10 Years After Radical Cystectomy and Adjuvant Chemotherapy

Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma – Analyses From the German Clinical RCC-Registry

Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?

Prognostic Value of Serum Cholinesterase in Non–muscle-invasive Bladder Cancer

Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer

Surgical High-risk Patients With ASA ≥ 3 Undergoing Radical Cystectomy: Morbidity, Mortality, and Predictors for Major Complications in a High-volume Tertiary Center

Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma

Evaluating the Current Place of Radiotherapy as Treatment Option for Patients With Muscle Invasive Bladder Cancer in Belgium

Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015

Influence of Gender and Age on the Willingness to Reduce Nicotine Consumption—Results of a Survey in Urological Cancer Patients (KRAUT Study)

Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience

Clinical Outcomes in Patients With Metastatic Papillary Renal-Cell Carcinoma: A Multi-Institutional Study in Japan

Cross-Sectional Patient-Reported Outcome Measuring of Health-Related Quality of Life With Establishment of Cancer- and Treatment-Specific Functional and Symptom Scales in Patients With Penile Cancer

Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study

Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery

Effect of Diphosphonates on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Approach for Renal Tumors With Low Nephrometry Score Through Unclamped Sutureless Laparoscopic Enucleation Technique: Functional and Oncologic Outcomes

Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome

Frontmatter

Editorial Board

Table of contents